The Strokefinder MD100 scan device trial is being conducted in the Hunter region. Credit: mi_viri/ shutterstock.com.

NSW [New South Wales] Ambulance in Australia is undertaking a pilot trial for the Strokefinder MD100 helmet brain scanner, aimed at transforming the rapid assessment and triage of stroke patients en route to hospital.

Developed by Medfield Diagnostics, the Strokefinder MD100 device is designed to assist in the clinical evaluation and triage of suspected intracranial injuries in acute situations.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Being conducted in the Hunter region, the new trial marks the first frontline use of the Strokefinder helmet technology outside of a hospital setting.

NSW Minister for Regional Health Ryan Park said the innovative trial could expedite stroke diagnosis and treatment, enhancing the chances of recovery during the critical ‘golden hour’.

NSW Ambulance Commissioner Dr Dominic Morgan said the technology is capable of performing multiple brain measurements in just 60 seconds.

See Also:

Dr Morgan added: “This exciting study brings together NSW Ambulance intensive care paramedics, John Hunter Hospital neurologists and the Hunter Medical Research Institute to evaluate the feasibility of the Strokefinder MD100 helmet in pre-hospital care.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“When combined with an innovative an innovative telehealth app, our paramedics on the ground are able to consult with the neurology team in the hospital to optimise the care and overall outcome for the stroke patient.”

The trial is led by John Hunter Hospital Acute Stroke Services neurologist Chris Levi. It involves a close collaboration between clinicians and researchers to assess and refine the stroke detection system and accompanying telehealth app for optimal frontline care.

Its impact was felt by Jack Di Tommaso, a 27-year-old gym owner who experienced an ischaemic stroke.

The Strokefinder MD100 scan was performed on Jack Di Tommaso within the ‘golden hour’, and his clinical data was captured in the telehealth app.

The collaborative effort between NSW Ambulance, Hunter New England Local Health District, Medfield Diagnostics, Hunter Medical Research Institute, and Titan Neuroscience Research Australia is expected to report the outcomes later in the year.